Showing 4 results for Immunity
Saeed Kianbakht , Ali Ghazavi, Zahra Ghafari , Masoumeh Kalantari, Marjan Mehri ,
Volume 6, Issue 1 (3-2003)
Abstract
Introduction: Saffron (crocus sativus L.), an important spice rich in carotenoids, is used in folk medicine to treat numerous diseases. This study examines the effects of saffron consumption on innate and humoral immunity of healthy male students.
Materials and Methods: 41 healthy volunteered university students in two control and case groups were included in this study and consumed respectively milk and milk containing saffron for 6 weeks. Blood samples were collected from the subjects at weeks 0, 3 and 6. Innate immunity was evaluated by determining the percentage and counts of monocytes, neutrophils, eosinophils, basophils, platelets and the total white cells, CRP concentration and C3 and C4 concentrations and humoral immunity was assessed by deterning the percentage of lymphocytes and the concentrations of IgG, IgM and IgA.
Results: Three weeks after saffron consumption, monocytes percentage and IgG concentration increased significantly (P<0.05, P=0.01). Total white blood cells and platelets count also reduced significantly (P<0.05). After 6 weeks, monocytes percentage and IgG concentration reduced significantly (P<0.05, P< 0.001) and platelets count increased significantly (P<0.05) as compared with week 3.
Conclusion: This investigation demonstrated that saffron consumption enhances innate and humoral immunity systems and has anti-inflammatory effects. These effects depending on the duration of saffron consumption.
Mohsen Khaki, Mostafa Ghavamian,
Volume 8, Issue 4 (12-2005)
Abstract
Introduction: Hepatitis B is a disseminated liver inflammation from HBV, that causes diseases and a large number of deaths. Regarding the fact that some of the vaccinated people are non responder (NR), evaluation of immunity in vaccinated ones and identification of NR especially in high risk group is necessary.
Materials and Methods: In this descriptive study blood samples of all medical students of Borujerd Azad university at the age of 18-25 and vaccinated personnel of Borujerd Shariaty hospital were tested for Anti.HBS-Ab level by ELISA method with Radim kit (cat.KHB31). Results were analyzed according to the number of received vaccines, the duration of vaccination and demographic criteria using descriptive statistics.
Results: About 90% of samples had protective immunity and 10% were NR. 8% of immune group had more than 1000, 17.2 % between 500-1000 and 74.8 % between 10-500 miu/ml of Ab titer. About 75% of immune samples had received two vaccines. In NR group 53% had received three vaccines and 47% had two. 4% of samples were immune with the duration less than one month after vaccination which 85 % of them had two vaccines.
Conclusion: Herd immunity was 90% which is accordant to most studies. In some studies with different results the effective criteria were not differentiated. So regarding these differences, vaccinated people are recommended to evaluate their HBS.Ab level.
Mohammad Reza Hashemzadeh, Mojtaba Saadati, Mohamadreza Baghaban Eslaminejad, Reza Aflatoonian, Mokhtar Zarea,
Volume 18, Issue 3 (6-2015)
Abstract
Background: Shigella is the causative agent of human shigellosis and its lipopolysaccharide is detected by TLR4. TLR4 belongs to Toll-like receptors family and many immunological pathways are triggered when these receptors are stimulated. Many researches showed increasing in TLR4 expression in mesenchymal stem cells through lipopolysaccharide treatment. The main goal of this study is detecting the optimum lipopolysaccharide between shigella strains through stimulation of immune system for vaccine studies.
Materials and Methods: In this experimental study human bone marrow derived mesenchymal stem cells were treated with three distinct concentrations (0.1, 0.01, and 0.001) of shigella (S. flexneri, S. dysenteriae, S. sonnei) extract containing lipopolysaccharide. Then TLR4 expression in mRNA level was investigated by RT-PCR and Q-PCR. The cells treated with phosphate buffered saline have been considered as a control group.
Results: Expression of TLR4 was shown in all of case groups except treatment with concentration 0.001 of extracts from sonnei and dysenteriae and also control group. The variations in the expression of TLR4 was dose-dependent in all of case groups. The maximum expression of TLR4 related to treatment with extract from shigella flexneri strain and the minimum expression related to treatment with shigella sonnei extract. The use of lipopolysaccharide from E. coli as a positive control indicated that lipopolysaccharide in shigella extracts is responsible for the increased expression of TLR4.
Conclusion: The TLR4 expression level was increasesed by S. flexneri extract, so it could be recommended for increasing vaccine efficiency.
Marzieh Rezaei, Mohammad Rabbani Khorasgani, Mohammad Reza Aliramaei,
Volume 23, Issue 6 (11-2020)
Abstract
Background and Aim: The genus of Lactococcus lactis belonging to the Lactic Acid Bacteria (LAB) group, is a gram-positive, faculative anaerobic, non-spore-forming, and non-motile bacterium. The present study aimed to introduce LAB, especially non-pathogenic, non-invasive, and safe Lactococcus lactis. Accordingly, we examined the previous studies concerning the advantages, limitations, promotion methods, and future prospects of oral vaccines based on this bacterium. This is because it is a potentially promising strategy for the vaccine production and prevention of some infectious diseases.
Methods & Materials: In this review article, 62 studies related to Lactococcus lactis and its application in producing oral vaccines were collected through searching databases, such as PubMed, Google Scholar, Scopus published from 1981 to 2020.
Ethical Considerations This article was approved by the Ethical Research Committee of Arak University of Medical Sciences with the number 1396/99.
Results: Lactococcus lactis, as a safe microorganism, is widely used in the food industry. Live recombinant Lactococcus lactis as a "biologic drug" is orally administered as one of the live vaccines expressing viral and bacterial antigens.
Conclusion: Recombinant Lactococcus-based vector can be suitable substitutes for live attenuated vaccines. Moreover, it can be a safe and food-grade host for manufacturing the desired products of human consumption over other systems. It also presents a high potential for vaccine delivery, especially through mucosal methods to prevent or treat certain diseases.
